Drugmakers to Benefit From Obama's Brain Initiative

April 2 (Bloomberg) -- President Barack Obama announced a U.S. campaign that may lead to new treatments for some of the least understood brain disorders, benefiting efforts by Pfizer, Roche and Eli Lilly. Shannon Pettypiece reports on Bloomberg Television's "Money Moves." (Source: Bloomberg)

Is Political Risk Premium Being Priced Into U.S. Assets?
25:24 - UniCredit Research Head of Global FX Vasileios Gkionakis discusses the political risk premium associated with President Trump, the dollar and unemployment. He speaks with on "Bloomberg Markets.” (Source: Bloomberg)
  • Apple Stock Rises as Pressure Mounts to Find Growth
  • London House Prices Post Biggest Drop in Six Years
  • RBS Rises After Scrapping Plans to Sell Williams & Glyn